| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.100 | None | 0.917 | 12 | 1 | 2012 | 2020 | |||||||||
|
psoriasis susceptibility 4 | 0.861 | 0.077 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2001 | 2014 | |||||||||
|
H3 histone pseudogene 13 | 0.584 | 0.769 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2008 | 2019 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2019 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2007 | 2019 | |||||||||
|
microRNA 31 | 0.471 | 0.769 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 2013 | 2019 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1993 | 2018 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2008 | 2018 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.060 | None | 0.833 | 6 | 0 | 2008 | 2018 | |||||||||
|
T helper type 2 locus control region associated RNA | 0.751 | 0.385 |
|
disease | 0.100 | None | 1.000 | 5 | 4 | 2009 | 2015 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2013 | 2018 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2004 | 2018 | |||||||||
|
psoriasis susceptibility 9 | 1.000 | 0.038 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2006 | 2014 | |||||||||
|
long intergenic non-protein coding RNA 1185 | 0.743 | 0.346 |
|
disease | 0.100 | None | 1.000 | 5 | 5 | 2010 | 2016 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | |||||||||
|
microRNA 203a | 0.471 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2018 | |||||||||
|
psoriasis susceptibility 6 | 0.931 | 0.038 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2003 | 2015 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 | 0.537 | 0.769 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2004 | 2006 | |||||||||
|
microRNA 223 | 0.433 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2019 | |||||||||
|
microRNA 99a | 0.536 | 0.808 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2011 | 2017 | |||||||||
|
psoriasis susceptibility 5 | 0.931 | 0.038 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2011 | |||||||||
|
psoriasis susceptibility 1 candidate 3 | 0.769 | 0.269 |
|
disease | 0.030 | None | 1.000 | 3 | 2 | 2005 | 2018 | |||||||||
|
glutamine amidotransferase like class 1 domain containing 3B | 0.636 | 0.577 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2018 |